From: Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)
Event | Â |
---|---|
All recorded events, n | 187 |
All events possibly treatment related, n | 4 |
Events per patient (min to max), n | 5 to 35 |
Severity (% of events) | Â |
   Mild | 58 |
   Moderate | 25 |
   Severe | 17 |
Non-serious events possibly treatment related, na | 4 |
   Supraventricular extrasystoles | 1 |
   ALT increased | 1 |
   AST increased | 1 |
   γ-Glutarate increased | 1 |
Serious adverse events (SAEs), nb | 4 |
   Heart failure/pulmonary oedema | 1 |
   Pulmonary infiltrates | 1 |
   Hypoxaemia/respiratory insufficiency | 2 |
Treatment-related SAEs, n | 0 |